Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

novartis_pic

Novartis drug PKC412 gets Breakthrough designation for AML

February 19, 2016 Medical Communications, Research and Development FDA, Novartis, acute myeloid leukaemia

Novartis’ PKC412 (midostaurin)  has become the latest in a sequence of FDA Breakthrough Therapy designations awarded this week- bagging the …
News

More evidence required for Alexion’s Kanuma, says NICE

February 18, 2016 Medical Communications, Research and Development Alexion, Kanuma, LAL-D, rare diseases

NICE says it needs additional trial data before it can recommend Alexion’s enzyme replacement therapy Kanuma (sebelipase alfa) for the …
News
antibiotics

Give GPs feedback on prescribing habits to reduce antibiotic use, says study

February 18, 2016 Medical Communications, Research and Development antimicrobial resistance

A trial of more than 1,500 GP practices has shown that sending general practitioners (GPs) letters giving feedback on their …
News
brexit

What would BREXIT mean for pharma?

February 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing research and development

It began with a promise to UK voters to end ‘benefit tourism’ and to negotiate more flexibility in the UK’s …
Feature
opdivo

UK patients get early access to Opdivo for kidney cancer

February 12, 2016 Medical Communications, Sales and Marketing

Bristol Myers-Squibb’s Opdivo (nivolumab) will be available through the Early Access to Medicines  Scheme (EAMS) as a monotherapy to UK …
News
amgen_flag

Amgen’s Kyprolis now available to UK multiple myeloma patients

February 12, 2016 Medical Communications, Sales and Marketing Amgen, Kyprolis, multiple myeloma

Amgen has announced the UK launch of Kyprolis (carfilzomib) in combination with Revlimid (lenalidomide) and dexamethasone for the treatment of …
News
fda

Biosimilars: Can the US catch up in 2016?

February 12, 2016 Medical Communications, Sales and Marketing Eli Lilly, Enbrel, FDA, Neulasta, Novartis, Pfizer, Sandoz, Zarxio, biosimilars

What are biosimilars? Biosimilars are essentially the biological equivalent of generic drugs to their branded small-molecule counterparts (what Ibuprofen is …
Feature
gsk_good_smaller

GSK fined millions over deals to delay generic competition

February 12, 2016 Medical Communications, Sales and Marketing GSK seroxat

GlaxoSmithKline has been fined £37.6m by the UK Competition & Markets Authority (CMA) for paying two generic drugmakers to delay …
News
sandoz_good

Sandoz buys rights to Pfizer biosimilar

February 12, 2016 Medical Communications, Research and Development, Sales and Marketing Pfiizer, Sandoz, biosimilars

Sandoz has announced further expansion to its biosimilars programme with the acquisition of the European rights to Pfizer’s Remicade (infliximab) …
News
abpi_logo

ABPI appoints Mike Thompson as new chief executive

February 11, 2016 Medical Communications

The Association of the British Pharmaceutical Industry (ABPI) has appointed former GlaxoSmithKline executive Mike Thompson as its new chief executive …
Appointment
carol_lynch

Sandoz’s Carol Lynch elected to chair European Biosimilars Group

February 10, 2016 Medical Communications biosimilars

The European Generic Medicines Association (EGA) has elected Carol Lynch, global head of Biopharmaceuticals & Oncology Injectables at Sandoz, as …
Appointment

NICE publishes new myeloma guidance

February 10, 2016 Medical Communications, Research and Development Farydak, Novartis, multiple myeloma

NICE has set out best practice for the diagnosis, monitoring and treatment of myeloma, in new guidelines published today. Myeloma …
News

Novartis says CDF proposals place “unreasonable” risk on pharma

February 10, 2016 Medical Communications, Research and Development, Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Novartis

Novartis has criticised some of the proposed changes to the way in which the UK Cancer Drugs Fund (CDF) is …
News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

New breast cancer initiative brings together pharma and Europe’s top researchers

February 9, 2016 Medical Communications, Research and Development Pfizer, breast cancer

The UK charity Breast Cancer Now (BCN) has announced a new initiative seeking to bring together Europe’s top researchers and …
News
aedes_aegypti_mosquito

INTERVIEW: Tackling the Zika threat

February 9, 2016 Manufacturing and Production, Medical Communications Zika, vaccines

The Zika outbreak which started in Brazil and spread rapidly to other south American countries and beyond has taken the …
Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026